D partnering in pharmaceutical biotechnology since 1975 : Trends , patterns , and networks

  title={D partnering in pharmaceutical biotechnology since 1975 : Trends , patterns , and networks},
  author={Nadine Roijakkers and John Hagedoorn},
This paper analyses a large, longitudinal database on inter-firm R&D partnerships formed in the high-tech pharmaceutical biotechnology industry since 1975. Our research indicates an overall growth in the number of annually, newly established R&D partnerships where research partners consistently prefer contractual partnerships to equity-based alliances. In the networks that develop through these R&D partnerships, small, entrepreneurial biotechnological companies take a leading role during the… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 35 extracted citations


Publications referenced by this paper.
Showing 1-10 of 30 references

Strategic alliances in commercial biotechnology

  • S. R. Barley, J. Freeman, R. C. Hybels
  • 1992
Highly Influential
6 Excerpts

The governance of innovation: vertical integration and collaborative arrangements in the biotechnology industry

  • G. P. Pisano
  • Research Policy 20,
  • 1991
Highly Influential
4 Excerpts

Three levels of networking for sourcing intellectual capital in biotechnology: implications for studying inter-organizational networks

  • J. B. Kruskal, M. Wish
  • International Studies of Management and…
  • 1978
Highly Influential
2 Excerpts

Dual market structures and the likelihood of repeated ties—evidence from pharmaceutical biotechnology

  • N. Roijakkers, J. Hagedoorn, H. van Kranenburg
  • Research Policy
  • 2005
2 Excerpts

Growth patterns in R & D partnerships : an exploratory statistical study

  • J. Hagedoorn, R. Narula
  • International Journal of Industrial Organization
  • 2003

The co-evolution of firms and their knowledge environment: insights from the pharmaceutical industry

  • F. Santos
  • Technological Forecasting and Social Change
  • 2003
2 Excerpts

Technological change and network dynamics. Lessons from the pharmaceutical industry

  • L. Orsenigo, F. Pammoli, M. Riccaboni
  • Research Policy 30,
  • 2001
2 Excerpts

Pharmaceutical firms and the transition to biotechnology: a study in strategic innovation

  • L. Galambos, J. L. Sturchio
  • Business History Review
  • 1998
1 Excerpt

Similar Papers

Loading similar papers…